intellectual property


Indian negotiators under pressure to give in to European Commission demands
Civil society and PLHIV networks across the world need to support us in this unequal and conclusive battle against the unfair demands of the European Commission on IP enforcement and investment standards.
Trade Commissioner: EU to seek GIs in US FTA, but no new ACTA
EU trade commissioner Karel De Gucht said he did not want to reopen the discussion on Anti-Counterfeiting Trade Agreement (ACTA), which he called “a nail to my coffin.” As long as there is no respective EU legislation with regard to copyright protection on the internet, he will not try to “bring it in through the backdoor,” he said.
Push for EU-US FTA could restart discussions about IPRs
The buzz around possible negotiations of a Transatlantic Free Trade Agreement (TAFTA) keeps growing, with European politicians pointing to agriculture and intellectual property as controversial topics.
USTR working to develop new text on IP and health in the TPP
USTR has begun an “internal review of the controversial pharmaceutical patent proposal that U.S. trade officials tabled” earlier in the TPP negotiations.
TPP traps - we need to know the costs as well as the gains
I'm not an economist, but I do understand what a net loss or a net gain is. Most people will be familiar with the concept - at the end of the day, are you better or worse off? To figure that one out you need to know what you've brought in, and what you've paid out.
The model BIT: A framework for intellectual property agreements
Article from Infojustice about using the US Model BIT framework to create model IPR Agreements and chapters to increase the legitimacy of international policy making in this area....
EU free trade deal will hike drug prices in N.S. — minister
A concession on drug patents in a free trade deal with the European Union stands to cost Nova Scotians millions, Health and Wellness Minister David Wilson said Wednesday.
Advocates ask de Gucht to leave data exclusivity out of trade agreement with Moldova
Health advocates have asked the EU not to include data exclusivity requirements in the “Deeply Comprehensive Free Trade Agreement” that is being negotiated between the EU and Moldova.
US pharma companies could be real beneficiaries of Canada-EU trade deal
Although the EU is asking Canada to change its patent regime, it is not possible to do so just for the EU. The actual beneficiaries would be all of the world’s brand-name companies. Of the world’s top 12 health care companies by revenue only three or four are resident in the EU.